Current location:Culture Circuit news portal > opinions
US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
Culture Circuit news portal2024-05-01 09:06:00【opinions】9People have gathered around
IntroductionWASHINGTON (AP) — Federal regulators are challenging patents on 20 brand name drugs, including the b
WASHINGTON (AP) — Federal regulators are challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic, in the latest action by the Biden administration targeting industry practices that drive up pharmaceutical prices.
The Federal Trade Commission on Tuesday sent warning letters to 10 drugmakers, taking issue with patents on popular drugs for weight loss, diabetes, asthma and other reparatory conditions. The letters allege that certain patents filed by Novo Nordisk, GlaxoSmithKline, AstraZeneca and seven other companies are inaccurate or misleading.
Brand-name drugmakers use patents to protect their medicines and stave off cheaper, generic medicines. Most blockbuster drugs are protected by dozens of patents covering various ingredients, manufacturing processes and intellectual property. Generic drugmakers can only launch their own cheaper versions if the patents have expired or are successfully challenged in court.
Address of this article:http://unitedstates.lochsaege.com/news-73b199868.html
Very good!(5)
Related articles
- Brazil soccer player Gabriel Barbosa cleared by CAS to play during appeal in doping rules case
- China releases full text of government work report
- China's experience with gender equality shared at UN
- Global South main force behind reforming international order, Wang says
- Brit living in California shares how expensive it really is to live there
- China releases full text of government work report
- Xi holds talks with Angolan president
- President Xi engages in lively discussion with deputies
- Bizarre moment yacht gets wedged underneath railway arches while being carried on a low
- China welcomes Hungary's visa facilitation measures: FM spokesperson
Popular articles
Recommended
Blow to Rishi Sunak's hopes for returning more small
SPP committed to law
China story is of benefiting the world, Wang Yi says
Palestinians seek unity with appointment of new PM
Portuguese
Resolving border issue 'in common interest' of China and India: Chinese FM
Top legislator addresses closing meeting of China's annual legislative session
Curb on Chinese talent sparks strong backlash
Links
- China Continues Crackdown on Irregularities of Off
- Xinhua Headlines: 9 Years on, Economic Ties Closer Among Belt and Road Countries
- 2022 World Artificial Intelligence Conference Held in Shanghai
- China Issues Action Plan to Boost Enterprise Innovation
- Featured Commodities from ASEAN Countries Attract Visitors at China
- Tourism Featuring ASEAN Cultures Heats up in Border Region
- China to See Population Shrink by 2025
- Village in China's Henan Transformed by Cultural Industries
- Mainland a Favorable Destination for Students from HK, Macao, Taiwan
- China Celebrates Farmers' Harvest Festival